Atropine Sulfate Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 01/01/2012.

Shortage Details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-580-20
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)
Initial Posting
01/01/2012
Revised Date